Besides this association with worse prognosis, recent studies demonstrate that patients with hormone-receptor-positive and HER2-negative BC have a higher resistance to hormonal treatment due to the action of enzymes from the APOBEC3 family. Here, NR4A1 is linked to breast cancer.